Allianz Asset Management Gmb H Nektar Therapeutics Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.64 - $3.15 $39,277 - $193,318	61,371 Added 42.9%	204,434 $143,000
Q4 2022 Feb 13, 2023	BUY	$2.03 - $4.28 $290,417 - $612,309	143,063 New	143,063 $323,000
Q4 2021 Feb 11, 2022	BUY	$10.83 - $18.41 $502,403 - $854,039	46,390 Added 224.43%	67,060 $910,000
Q3 2021 Nov 10, 2021	SELL	$13.07 - $18.84 $65,350 - $94,200	-5,000 Reduced 19.48%	20,670 $371,000
Q1 2021 May 13, 2021	BUY	$16.56 - $25.46 $425,095 - $653,558	25,670 New	25,670 $513,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $411,833 - $496,968	-26,115 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $94,845 - $141,724	-5,717 Reduced 17.96%	26,115 $433,000
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $94,854 - $131,873	-5,626 Reduced 15.02%	31,832 $737,000
Q1 2020 May 14, 2020	SELL	$14.47 - $27.96 $286,202 - $553,020	-19,779 Reduced 34.56%	37,458 $669,000
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $724,211 - $1.06 Million	45,634 Added 393.29%	57,237 $1.24 Million
Q3 2019 Nov 13, 2019	SELL	$16.91 - $36.27 $450,600 - $966,486	-26,647 Reduced 69.67%	11,603 $211,000
Q2 2019 Aug 08, 2019	SELL	$31.0 - $36.3 $49,290 - $57,716	-1,590 Reduced 3.99%	38,250 $1.36 Million
Q1 2019 May 13, 2019	BUY	$31.58 - $46.35 $127,899 - $187,717	4,050 Added 11.32%	39,840 $1.34 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $1.09 Million - $2.03 Million	35,790 New	35,790 $1.18 Million
Q3 2018 Nov 13, 2018	SELL	$46.46 - $68.49 $1.85 Million - $2.73 Million	-39,798 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$46.25 - $104.45 $2.95 Million - $6.67 Million	-63,886 Reduced 61.62%	39,798 $1.94 Million
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $643,626 - $1.22 Million	11,213 Added 12.13%	103,684 $11 Million
Q4 2017 Feb 13, 2018	SELL	$23.02 - $60.5 $366,892 - $964,249	-15,938 Reduced 14.7%	92,471 $5.52 Million
Q3 2017 Nov 13, 2017	BUY	$17.79 - $24.0 $133,549 - $180,168	7,507 Added 7.44%	108,409 $2.6 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-18,298 Reduced 15.35%	100,902 $1.96 Million
Q1 2017 Apr 17, 2019	BUY	N/A	7,983 Added 7.18%	119,200 $2.78 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-86,485 Reduced 43.75%	111,217 $1.37 Million
Q3 2016 Apr 17, 2019	BUY	N/A	197,702	197,702 $3.35 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$14.5 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$13.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$11.9 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.55 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.37 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $171M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account